Vascular Solutions
AI-powered plaque image analysis for stent deployment
Company profile
Company profile
Dyad Medical, Inc. is a pioneer solution provider specializing in automated cardiac and cardiovascular image analysis using artificial intelligence and machine learning. The company's platform combines deep learning techniques with big data analytics to help medical professionals analyze medical images with greater accuracy and efficiency. Dyad Medical provides cardiologists with insights on every scan they perform, regardless of the modality used or what part of the heart they scan. The platform delivers instantaneous cardiac image interpretations globally via the web, accessible by any device, functioning like having thousands of expert second opinions available in real-time. The company specializes in multiple imaging modalities including Echocardiogram Video and Still Image Analysis for physiologic assessment of the heart and its valves, enabling quick diagnosis and triage of patients. Dyad Medical also has an Intravascular Optical Coherence Tomography (IVOCT) solution pending FDA approval that will aid in analyzing plaque images and facilitate stent deployment. The company's technology is designed to reduce human error and misdiagnosis, reduce costs, improve workflow efficiency, and enable collaboration among medical experts. By teaching computers to automatically analyze medical images, Dyad Medical aims to provide universal access to expert-level observations for clinicians worldwide.
Company description Dyad Medical, Inc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Company milestones
IVOCT solution pending FDA approval for plaque image analysis and stent deployment assistance
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered plaque image analysis for stent deployment
AI-powered automated cardiac and cardiovascular image analysis platform
AI-powered echocardiogram analysis for quick diagnosis and triage
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Journal of clinical medicine · Nov 18, 2025
Clinical validation
No linked records are currently available.
Regulatory
K220956 · 510k · Jul 20, 2022
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Through automated AI-based analysis
By improving workflow efficiency
For complicated cardiac procedures
Through echocardiogram analysis
05 · Leadership
Leadership profiles and professional links from the current Company record.
Ronny Shalev
Co-Founder & CEO
06 · Company updates
Recent articles published on Dyad Medical, Inc's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.